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The pZ 4.7, 14.5 kDa hematoxylin-stainable protein (HSP) from rat epidermis inhibited the activities of the cysteine proteinases papain, ficin, cath- 
epsins B, H and L with similar inhibitory characteristics as recombinant cystatin-a. Proteinases of other classes were not inhibited. The inhibitory 
activity of HSP was heat stable in the wide pH range of 3.0-10.0. Polyclonal antibodies against HSP cross-reacted with cystatin-a nd the molecular 
mass of HSP was similar to that of cystatin-a, though its isoelectric point was different. The in vivo location of both HSP and cystatin-a is on 
keratohyalin granules in epidermis as detected by indirect immunofluorescence technique using individual antibodies. Therefore it is highly probable 
that HSP is a cystatin-a derivative or a very similar proteinase inhibitor belonging to a family of cystatins. 
Cysteine proteinase inhibitor; Keratohyalin granule; Hematoxylin stainable protein; Cystatin-a 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Cysteine proteinase inhibitors have been isolated 
from various mammalian tissues and are divided into 3 
groups of families [l]. Some cysteine proteinase in- 
hibitors were isolated from human and rat skins, and 
characterized [2,3]. One of them, cystatin-cu, which 
belongs to family 1, has a low molecular weight and has 
been found in the skin in high levels, especially in the 
epidermal cells [4]. However, its in vivo location has 
not been clarified yet. Recently, we have isolated an 
acidic, hematoxylin-stainable protein component 
(HSP) of keratohyalin granules (KHG) [5,6]. As shown 
in Table I, the amino acid composition of HSP was 
found to be similar to that of cysteine proteinase in- 
hibitors isolated by Takeda et al., named TPI( 1) [7] and 
Takio et al., named rat epidermal TPI [8]. This finding 
suggested that HSP could be a member of the cystatin 
superfamily and may inhibit cysteine proteinases. 
In this work, the inhibitory properties of HSP were 
investigated and found to be similar to those of 
cystatin-a. Further similarities of HSP, to cystatin-cu 
were found in molecular mass, immunological reaction 
and tissue distribution. 
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2.1. Materials 
Papain, ficin, chymotrypsin, thermolysin, casein and p-nitro- 
anilide substrates were purchased from Sigma (USA). Trypsin was 
obtained from Difco (USA). Rat cathepsins B, H and L were purified 
as described [9-l 11. Aminomethylcoumarin substrates were pur- 
chased from Peptide Institute (Japan). Superose 12 and Mono-Q col- 
umns and ampholines were ordered from Pharmacia-LKB (Sweden). 
Lowicryl K4M embedded kit was obtained from TAAB Laboratories 
(UK). Recombinant cystatin-cr and polyclonal antibodies against it 
were kindly provided by Dr T. Ohshita (Division of Enzyme 
Table 1 
Comparison of amino acid composition 
HSP [6] TPI(1) 171 Rat epidermal 
TPI [8] 
Half-Cys 0 0 - 
Asx 12.0 12.4 11.3 
Thr 7.3 8.7 6.4 
Ser 3.6 5.3 3.9 
Glx 14.3 15.1 13.8 
Pro 3.3 6.9 4.1 
GlY 10.0 9.6 9.4 
Ala 4.5 3.9 5.0 
Val 8.0 9.7 8.7 
Met 2.6 2.7 2.7 
Ile 2.2 2.7 2.9 
Leu 8.7 9.3 8.8 
Tyr 2.9 2.3 2.9 
Phe 4.0 4.1 4.0 
His 1.2 1.5 1.3 
LYS 13.7 13.7 11.6 
Arg 3.2 3.0 3.3 
Total 101.5 110.9 103 
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Table 11 
Purification of the HSP from newborn rat epidermis 
Step Total protein Activitya Yield 
(mg) (%) 
(U) (U/mg) 
Tris-HCl epidermal 
extract 
Isoelectric focusing 
Superose 12 
Mono-Q 
740 155.4 0.21 100 
125 46.3 0.37 29.8 
47.6 39.0 0.82 25.1 
23.1 23.6 1.02 15.2 
a The inhibition was expressed as mg of papain inhibited by 1 mg of 
inhibitor (U/mg) 
Chemistry, Institute for Enzyme Research, The University of 
Tokushima) [12]. 
2.2. Purification of HSP and production of polyclonal antibodies 
Rat HSP was purified to homogeneity by 2-dimensional electro- 
phoresis as described previously [6]. Three-day-old rat (Sprague- 
Dawley strain) epidermal extract in 50 mM Tris-HCl (pH 7.4) was 
subjected to preparative isoelectric focusing, Superose 12 gel filtra- 
tion and Mono-Q anion-exchange column chromatography. PoAbs 
against thus purified HSP were produced in rabbits. 
2.3. Assay of inhibitory activity 
The inhibitory activities of HSP and the recombinant cystatin-cu 
[8,12] on papain, ficin [7], pepsin [13] and thermolysin [14] were 
assayed using casein or authenticp-nitroanilide substrates; the absor- 
Fig. 1. Two-dimensional electrophoreses of HSP (A), cystatin-cu (B) and mixture of these proteins (C), and immunoblotting analyses of HSP (D) 
and cystatin-cu (E) using anti-HSP PoAb. (Lane M) Molecular mass markers (descending): phosphorylase b (94 kDa), bovine serum albumin 
(67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), soybean trypsin inhibitor (20.1 kDa) and lactalbumin (14.4 kDa). 
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bance was monitored at 280 or 410 nm. Activity of cathepsins B, H 
and L was assayed fluorometrically using aminomethylcoumarin 
substrates according to the method of Barrett and Kirschke [15]. 
Fluorescence was excited at 370 nm and monitored at 460 nm. The 
K, value was determined by Dixon’s method [16]. 
2.4. Two-dimensional electrophoresis and immunoblotting analysis 
Two-dimensional electrophoresis for HSP and cystatin-cu, and im- 
munoblotting using PoAb against HSP were performed according to 
O’Farrell et al. [17] and Towbin et al. [18], respectively. 
2.5. Localization of HSP and cystatin-a 
The Lowicryl-embedded sections of newborn rat skin, previously 
fixed with 0.025% glutaraldehyde/2% paraformaldehyde, were 
prepared according to Roth et al. [19]. The in vivo location was 
demonstrated by immunofluorescent technique using PoAbs against 
HSP and cystatin-cu. 
Fig. 2. In vivo location of HSP and cystatin-cu by indirect 
immunofluorescence. Specific fluorescence was observed when the 
Lowicryl K4M-embedded section was reacted with anti-HSP PoAb 
(A) and anti-cystatin-cu PoAb (B) and staining obtained with HE stain 
(C). A, B and C: x 120. Arrows indicate KHG. Dotted lines indicate 
epidermal-dermal junction. 
Table III 
Comparison of the inhibitory activities of HSP and cystatin-cu for 
various proteinases 
Enzyme Substrate lD50’ 
HSP Cystatin-cu 
Cysteine proteinases 
Papain BAPNA 5.8 pg 
(Ki = 270 nM) 
casein 14.6 pg 
Ficin BAPNA 6.9 pg 
casein 7.1 Yg 
Z-Phe-Arg-MCA 0.26 ng 0.17 ng 
Cathepsin B Z-Arg-Arg-MCA 23.5 ng 14.6 ng 
Cathepsin H Arg-MCA 0.6 ng 0.22 ng 
Cathepsin L Z-Phe-Arg-MCA 1.3 PF3 7.7 Pg 
Serine proteinases 
Trypsin BAPNA > 50.0 yg 
Chymotrypsin Bz-Tyr-PNA > 50.0 pg 
Carboxy proteinase 
Pepsin casein > 50.0 pg 
Metallo proteinase 
Thermolysin casein >50.0tg 
a Amount necessary for 50% inhibition of activity 
3. RESULTS 
The inhibitory activity and the yields of HSP after 
each purification step are summarized in Table II. 
Purified HSP displayed a single protein spot on 
2-dimensional electrophoresis (Fig. 1A). As shown in 
Fig. lC, its isoelectric point was different from that of 
cystatin-cu, though the molecular weights were quite 
similar. PoAb against HSP cross-reacted with cys- 
tatin-cu (Fig. 1E). The location of HSP and cystatin-a 
using indirect immunofluorescent echnique by anti- 
HSP and anti-cystatin-rr PoAbs were identical as 
shown in Fig. 2A and B. And the profiles were well cor- 
related with the distribution pattern of KHG in HE- 
stained specimen (Fig. 2C). 
HSP inhibited only cysteine proteinases and not pro- 
teinases of other classes. The inhibitory activity of HSP 
against various proteinases is summarized in Table III, 
and compared with that of cystatin-cu. Both HSP and 
cystatin-cu inhibited the activities of various cysteine 
proteinases to a similar degree. The Ki value of HSP for 
papain was found to be 270 nM using BAPNA as the 
substrate. The inhibitory activity of HSP was rather 
stable to heat and extreme pHs. 
4. DISCUSSION 
Hematoxylin-stainable component protein of KHG 
was isolated and characterized as a cysteine proteinase 
inhibitor. Cysteine proteinase inhibitors have been 
reported to be located diffusely in the cytoplasm of the 
living cell layers, especially in the stratum spinosum or 
the stratum granulosum [3,20,21]. However, we found 
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HSP as well as cystatin-a to be located on KHG by in- 
direct immunofluorescent echniques using anti-HSP 
and anti-cystatin-cu PoAbs, respectively. As HSP is 
quite similar to cystatin-a in their molecular weights, 
amino acid compositions and inhibitory activities, HSP 
and recombinant cystatin-cy [12] were examined by the 
immunoblotting technique using anti-HSP PoAbs. As 
both reacted with these PoAbs to the same extent, both 
should have many common epitopes in their molecules. 
The inhibitory activities of both HSP and cystatin-a 
against ficin were similar. Both had similar inhibitory 
activity against cysteine cathepsins increasing in the 
order cathepsin B, H and L. The amino acid compo- 
sitions are quite similar to TPI(l) [7] and rat epidermal 
TPI [8]. Our preliminary observations how that the N- 
terminus of HSP is masked and the C-terminus of HSP 
is phenylalanine, being identical to that of cystatin-cu, 
although complete amino acid sequence of HSP is not 
determined yet. On the basis of these data, it may be 
assumed that the amino acid sequence of HSP is quite 
similar to that of cystatin-a or is the same. In addition, 
it is possible to assume that HSP is phosphorylated as 
reported by Laber et al. in a similar manner as egg 
white cystatin [22]. 
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